Josie Montegaard, NP, who spoke about CLL at JADPRO Live 2023, discusses how she hopes to see the field move forward. Speakers from a JADPRO Live session on CLL outline what providers need to know about personalizing therapy for CLL. Amber Koehler, MPAS, PA-C, shares what providers need to know about the 2 main categories of frontline therapy for CLL. Amber Koehler, MPAS, PA-C, and Josie Montegaard, NP, shared their insights during JADPRO Live, the Annual APSHO Meeting. The patients receiving a dose adjustment had a mean age of 72.2 years and 42.9% were women. APPs play a vital role in early recognition of symptoms of rheumatologic autoimmune diseases in patients with CLL.